Does WARFARIN Cause Injection site discolouration? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Injection site discolouration have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.0% of all adverse event reports for WARFARIN.
7
Reports of Injection site discolouration with WARFARIN
0.0%
of all WARFARIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site discolouration From WARFARIN?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
GLATIRAMER (270)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)